Montigny le Bretonneux, France

Agnes Thomas-Collignon

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2016-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Agnes Thomas-Collignon: Innovator in Aesthetic Dermatology

Introduction

Agnes Thomas-Collignon is a prominent inventor based in Montigny le Bretonneux, France. She has made significant contributions to the field of aesthetic dermatology, particularly through her innovative patents. With a total of two patents to her name, her work focuses on treating aesthetic defects in the skin.

Latest Patents

Agnes Thomas-Collignon's latest patents include a groundbreaking process for treating individuals with aesthetic defects of the skin by modulating the SASPase-FLG2 complex. This invention relates to the use of a compound that modulates the interaction between SASPase and filaggrin-2 (FLG2) proteins. The active agent aims to treat and prevent aesthetic defects linked to imbalances in the differentiation and proliferation of epidermal cells. Another notable patent involves peptides that modulate the SASPase-FLG2 complex. This isolated peptide can modify the three-dimensional shape of the complex formed by the interaction between filaggrin-2 and SASPase, making it useful for screening cosmetic or therapeutic agents for skin applications.

Career Highlights

Agnes Thomas-Collignon is associated with L'Oréal, a leading company in the beauty and cosmetics industry. Her work at L'Oréal has allowed her to apply her innovative ideas in a practical setting, contributing to advancements in skincare products.

Collaborations

Agnes has collaborated with notable colleagues, including Dominique Bernard and Roger Rozot. These collaborations have further enriched her research and development efforts in the field of aesthetic dermatology.

Conclusion

Agnes Thomas-Collignon is a trailblazer in the realm of aesthetic dermatology, with her patents paving the way for new treatments in skincare. Her contributions reflect a commitment to innovation and excellence in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…